泓博医药

301230
26.851.29% ( -0.35 )
延迟 开市竞价中: 11月19日 09:25:00

股东

全部股东

股东类型

  • 公众及其他42.04%
  • 私营企业32.22%
  • 个人与内部人士13.53%
  • 机构投资者12.21%

主要股东

主要股东 最新
股东
PharmaResources Holding Co. Ltd.
22.99%4,120.44 万0.00%+0
Rongchang AnFounder & Director
7.77%1,392.39 万0.00%+0
Shengli JiangDeputy GM & Director
5.74%1,029.21 万0.00%+0
Shenyang Fubang Investment Co., Ltd.
5.29%948.12 万0.00%+0
Shanghai Dingyun Investment Management Consulting Partnership Enterprise (Limited Partnership)
3.93%705.07 万0.00%+0
Shenzhen Qianhai Yingyuntong Investment Holding Co., Ltd.
2.90%520.00 万0.00%+0
Beijing Zhongfu Investment Management Company
2.03%364.36 万0.00%+0
Great Wall Fund Management Co., Ltd
1.09%195.12 万0.00%+0
Dingtai Haifu Investment Management Co., Ltd.
1.02%182.70 万0.00%+0
Golden Trust SinoPac Fund Management Co., Ltd.
0.74%132.55 万0.00%+0
Lion Fund Management Co. Ltd.
0.71%127.90 万0.00%+0
GF Fund Management Co., Ltd.
0.71%126.72 万0.00%+0
Guorong Fund Management Co., Ltd.
0.66%119.03 万0.00%+0
JPMorgan Chase & Co.
0.55%98.17 万0.00%+0
Broad Asset Management Co., Ltd
0.29%52.57 万0.00%+0
First State Cinda Fund Management Company Limited
0.29%52.12 万0.00%+0
Zhong Ou Fund Management Co., Ltd
0.29%51.32 万0.00%+0
Wanjia Asset Management Co., Ltd.
0.17%31.24 万0.00%+0
ICBC Credit Suisse Fund Management Co., Ltd
0.13%23.04 万0.00%+0
China Merchants Fund Management Company Ltd.
0.12%22.06 万0.00%+0